SEC Filing Summary: Aziyo Biologics, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on May 10, 2023, by Aziyo Biologics, Inc. (AZYO), a Delaware corporation listed on the Nasdaq Capital Market. The report covers two primary events: the announcement of financial results for the first quarter ended March 31, 2023, and a regulatory notice received on May 4, 2023, regarding continued listing standards.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing the Q1 2023 results of operations but does not explicitly state specific revenue, profit, cash flow, margin, debt, or liquidity figures within the text of this 8-K. The filing notes that the company does not meet the Nasdaq Net Income Standard, implying a lack of profitability, but specific values are not provided in this document.
Material Changes and Listing Status
On May 4, 2023, Aziyo received a notice from Nasdaq stating that for 30 consecutive business days, its Market Value of Listed Securities (MVLS) fell below the required minimum of $35 million. Additionally, the company does not meet the Equity Standard or the Net Income Standard. This constitutes a material change in the company's listing status, triggering a compliance period.
Outlook, Risks, and Contingencies
- Compliance Period: The company has 180 calendar days (until October 31, 2023) to regain compliance with the Market Value Standard.
- Delisting Risk: If the MVLS does not close at or above $35 million for 10 consecutive business days before the compliance deadline, the stock may be subject to delisting.
- Alternative Compliance: The company may attempt to regain compliance by demonstrating stockholders' equity of at least $2.5 million or net income from continuing operations of $500,000 in the most recent fiscal year or two of the three most recent fiscal years.
- Appeal Process: If delisting is imminent, the company may appeal to a Hearings Panel, though success is not assured.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2023 revenue, net loss, and cash burn figures not detailed in this 8-K.
- Monitor the daily closing price and share count to calculate the current Market Value of Listed Securities (MVLS).
- Verify the company's current stockholders' equity and net income status to assess eligibility for alternative listing standards.
- Track any future announcements regarding capital raises or strategic actions intended to restore MVLS compliance before October 31, 2023.